A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF OZANIMOD, AN ORAL S1P RECEPTOR MODULATOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF THE MAINTENANCE PERIOD OF THE TOUCHSTONE STUDY
William Sandborn 1
Brian G. Feagan 2
Douglas C. Wolf 3
Geert R. D'Haens 4
Severine Vermeire 5
Stephen B Hanauer 6
Subrata Ghosh 7
Heather Smith 8
Matt Cravets
Paul A. Frohna
Richard Aranda
Sheila Gujrathi
Allan Olson
1 University of California,San Diego,United States
2 Robarts Research,London,Canada
3 Atlanta Gastroenterology Associates ,Atlanta,United States
4 Academic Medical Center,Amsterdam,Netherlands
5 University of Leuven,Leuven,Belgium
6 Feinberg School of Medicine,Chicago,United States
7 University of Calgary,Alberta,Canada
8 Receptos,San Diego,
Conference
UEG Week 2015
Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]